The life sciences industry has always been shaped by waves of disruption, but in 2025 the turbulence feels more structural than cyclical. Early-stage companies and their investors now find themselves facing delayed...
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
When considering early-stage investment opportunities, many investors emphasize the team over the business opportunity, i.e., they bet on the jockey more than the horse. However, in the realm of life science startup...
In the ever-evolving healthcare landscape, technological innovations continue to drive significant advancements. In this article, we delve into the realm of medical device investment, exploring key trends,...
In the past year, we saw great achievements across our portfolio of high-impact life science companies despite a challenging overall fundraising environment. Our VIC Tech team and the portfolio company teams showed...
In healthcare, a paradigm shift is underway – one that promises to transform healthcare as we know it. The emergence of personalized medicine, fueled by groundbreaking advancements in genomics and diagnostics, can save...
Within the VIC Tech portfolio, SFC Fluidics and Solenic Medical have both announced FDA Breakthrough Device designation. But what is FDA Breakthrough Device designation and what benefits does it provide? From a...
In the world of early stage investing, traditional venture capital funds have long been the go-to option for investors seeking exposure to high-growth opportunity companies. However, a different investment model is...
Investing in a life science startup can be a lucrative opportunity, but it requires careful evaluation to weigh the potential reward against the level of risk. Members of VIC Tech's affiliated VIC Investor Network...
As CEO of VIC Tech, I am fortunate to have the opportunity to review exciting new life science technologies on an ongoing basis and regularly speak with life science thought leaders, inventors, investors, and large...
FEATURED RESOURCES
